{"stewardOrg":{"name":"NCI"},"createdBy":{"username":"NIH CDE Repository Team"},"updatedBy":{"username":"NIH CDE Repository Team"},"property":{"concepts":[{"name":"Illicit Substance","origin":"NCI Thesaurus","originId":"C79097"},{"name":"Amphetamine","origin":"NCI Thesaurus","originId":"C62006"},{"name":"CNS Stimulant","origin":"NCI Thesaurus","originId":"C47795"},{"name":"Assessment","origin":"NCI Thesaurus","originId":"C25367"}]},"dataElementConcept":{"concepts":[{"name":"Timeline Followback Method Illicit Substance Amphetamine Stimulant Assessment","origin":"NCI caDSR","originId":"3703162v1"}]},"objectClass":{"concepts":[{"name":"Timeline Followback Method","origin":"NCI Thesaurus","originId":"C105552"}]},"valueDomain":{	"definition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","name":"Yes No Indicator","datatype":"Value List","permissibleValues":[{"permissibleValue":"No","valueMeaningName":"No","valueMeaningDefinition":"The non-affirmative response to a question.","valueMeaningCode":"C49487","codeSystemName":"NCI Thesaurus"},{"permissibleValue":"Yes","valueMeaningName":"Yes","valueMeaningDefinition":"The affirmative response to a question.","valueMeaningCode":"C49488","codeSystemName":"NCI Thesaurus"}],"ids":[],"identifiers":[]},"elementType":"cde","sourcesNew":{},"history":["555ce98c21424b11152a9788","578933c358c536c17a7ba703","5798f8342ae1928632c64f16"],"archived":false,"views":0,"_id":"589896b0784d74fc260af95c","created":"2015-05-20T20:07:40.921Z","tinyId":"XkNvp_Q1kg","imported":"2016-07-27T14:26:12.177Z","source":"caDSR","version":"1","origin":"Timeline Followback Method","__v":3,"updated":"2017-02-06T15:30:56.481Z","changeNote":"Modified Tag from Health to Long Name","lastMigrationScript":"fixDataElement","derivationRules":[],"referenceDocuments":[],"attachments":[{"uploadedBy":{"username":"BatchLoader"},"fileid":"5798f8342ae1928632c64f18","filename":"3703190v1.xml","filetype":"application/xml","uploadDate":"2016-07-27T18:06:44.221Z","comment":"Original XML File","filesize":10536}],"comments":[],"mappingSpecifications":[],"dataSets":[],"ids":[{"source":"caDSR","id":"3703190","version":"1"}],"properties":[{"key":"caDSR_Context","source":"caDSR","value":"NIDA"},{"key":"caDSR_Datatype","source":"caDSR","value":"CHARACTER"},{"key":"caDSR_Short_Name","source":"caDSR","value":"3703162v1.0:3506068v1.0"},{"key":"caDSR_Registration_Status","source":"caDSR","value":"Empty"}],"classification":[{"stewardOrg":{"name":"NIDA"},"elements":[{"elements":[{"name":"Timeline Followback Method Assessment","elements":[{"name":"Timeline Followback Method Assessment","elements":[]}]}],"name":"Clinical Research"}]}],"registrationState":{"registrationStatus":"Qualified","administrativeStatus":"RELEASED"},"sources":[{"sourceName":"caDSR"}],"definitions":[{"tags":["Long Name"],"definition":"the yes/no indicator that asks whether the participant had used amphetamine-type stimulants, which includes methamphetamine (speed, crystal meth, ice), misuse of prescription stimulant medications, such as methylphenidate (Ritalin, Concerta), dextroamphetamine (Dexedrine), mixed amphetamine salts (Adderall), and diet pills as part of the Timeline Followback Method assessment, a calendar-based measure for assessing self-reported retrospective daily estimates of alcohol, tobacco and/or illicit substance use."},{"tags":["Preferred Question Text"],"definition":"Amphetamine-type stimulants"}],"designations":[{"tags":["Long Name"],"designation":"Timeline Followback Method Illicit Substance Amphetamine Stimulant Assessment Yes No Indicator"},{"tags":["Preferred Question Text"],"designation":"Amphetamine-type stimulants"}],"_links":{"describedBy":{"href":"/meta/schemas/example"}}}